567 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Ginkgo Bioworks Acquisitions

Ginkgo Bioworks has acquired 13 companies and its latest acquisition was Modulus Therapeutics, Inc. on Apr 2024

Unlock 10 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Modulus Therapeutics, Inc.

Apr 2024

Source »
undisclosed
Modulus Therapeutics is a Washington-based cell engineering company that develops cell therapy drug discovery solutions for the treatment of autoimmune diseases.

-

AgBiome's Microbial Strain Library and Product Concepts Pipeline

Apr 2024

Source »
undisclosed
-
Proof Diagnostics, Inc.

Feb 2024

Source »
undisclosed
Proof Diagnostics is a Massachusetts-based medical device company that manufactures and supplies CRISPR-based COVID-19 molecular testing equipment for the healthcare industry.
Patch Biosciences

Feb 2024

Source »
undisclosed
Patch is a New York-based AI platform that provides DNA sequencing solutions for gene therapy applications.
Reverie Labs, LLC

Feb 2024

Source »
undisclosed
Reverie Labs is a Massachusetts-based pharmaceutical company that researches and develops kinase inhibitors for the treatment of cancer.

Frequently Asked Questions about Ginkgo Bioworks

  1. What companies did Ginkgo Bioworks acquire?

    Companies acquired by Ginkgo Bioworks include Modulus Therapeutics, and Proof Diagnostics

  2. How many acquisitions does Ginkgo Bioworks have?

    Ginkgo Bioworks has acquired 13 companies including Modulus Therapeutics, and Proof Diagnostics.

  1. How many acquisitions did Ginkgo Bioworks make in 2024?

    In 2024 Ginkgo Bioworks acquired 5 companies including Modulus Therapeutics, and Proof Diagnostics.